Abstract
Objective
Brain radiotherapy is the main treatment for patients with brain metastases but its goal is just symptom control. Our aim was to study if different performance tools, used in geriatric practice, could improve patient selection for decision-making in the palliative brain radiotherapy setting.
Patients and methods
Data from 61 consecutive patients were analysed. In addition to Karnofsky Performance Status (KPS) their physical activity was assessed by means of the activity of daily living (ADL) and instrumental ADL (IADL) scales. A neurocognitive evaluation was performed with the Pfeiffer Short Portable Mental Status Questionnaire (SPMSQ) and with the Mini-Mental Status Exam (MMSE). Radiotherapy compliance and short survival were the endpoints of the study.
Results
High rates of cognitive impairment were found by both neurocognitive tools (Pfeiffer: 19.7% of patients; MMSE: 30%). Dependence was also highly prevalent, either measured by the ADL (50.8%) or by the IADL (43.3%). Nearly one third (27.9%) of patients died soon after radiotherapy evaluation. Longer survival was related to female, younger than 60 years, breast cancer primary tumour, steroid response, RPA class, and higher performance and neurocognitive score tools. A premature death was associated with neurocognitive tools, IADL and longer interval from brain metastatic diagnosis to radiotherapy. Twenty-three percent of patients were not able to finish the WBRT course due to clinical deterioration. The only variable related to compliance was a low MMSE score.
Conclusions
Results suggest that the geriatric tools analysed could offer information on brain palliative radiotherapy complementary to that offered by the more usual tools. It will be interesting to study if our data could be extrapolated to the general palliative oncological field.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Clayton A, Danson S, Jolly S et al (2004) Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer 91:639–643
Gaspar L, Scott C, Rotman M et al (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Bio Phys 37:745–751
Langer C, Mehta M (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219
Soffietti R, Costanza A, Laguzzi E et al (2005) Radiotherapy and chemotherapy of brain metastases. J Neurooncol 75:31–42
Mehta M, Rodrigus P, Terhaard C et al (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and wholebrain radiation therapy in brain metastases. J Clin Oncol 21:2529–2536
Tsao M, Lloyd N, Wong R et al (2005) Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 31:256–273
Rades D, Bohlen G, Dunst J et al (2008) Comparison of short-course versus long-course wholebrain radiotherapy in the treatment of brain metastases. Strahlenther Onkol 184:30–35
Nieder C, Nestle U, Motaref B et al (2000) Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? Int J Radiat Oncol Biol Phys 46:297–302
Rades D, Dunst J, Schild SE (2008) A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 184:251–255
Nieder C (2008) Two new prognostic indices for brain metastases: where do we go from here? Strahlenther Onkol 184:488–489
Glare P, Virik K, Jones M et al (2005) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327:195–200
Christakis N, Lamont E (2000) Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort study. BMJ 320:469–473
Chow E, Davis L, Panzarella T et al (2005) Accuracy of survival prediction by palliative radiation oncologists. Int J Radiat Oncol Biol Phys 61: 870–873
Barnes EA, Chow E, Tsao MN et al (2010) Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy. Int J Radiat Oncol Biol Phys 76:187–192
Repetto L, Comandini D, Mammoliti S (2001) Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol 37:147–152
Larson EB, Shadlen MF, Wang L et al (2004) Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 140:501–509
Schupf N, Tang MX, Albert SM et al (2005) Decline in cognitive and functional skills increases mortality risk in nondemented elderly. Neurology 65:1218–1226
Neale R, Brayne C, Johnson AL (2001) Cognition and survival: an exploration in a large multicentre study of the population aged 65 years and over. Int J Epidemiol 30:1383–1388
Nguyen HT, Black SA, Ray LA et al (2003) Cognitive impairment and mortality in older Mexican Americans. J Am Geriatr Soc 51:178–183
Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 23:433–441
Lobo A, Saz P, Marcos G et al (1999) Revalidation and standardization of the cognition miniexam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population [in Spanish]. Med Clin 112:767–774
Folstein M, Folstein S, McHugh P (1975) Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psiquiatr Res 12:189–198
Mahoney F, Barthel D (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61–65
Lawton M, Brody E (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Rades D, Kueter JD, Hornung D et al (2008) Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases. Strahlenther Onkol 184:655–662
Lagerwaard F, Levendag P, Nowak P et al (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803
Rades D, Dunst J, Schild SE (2008) A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 184:251–255
Rades D, Pluemer A, Veninga T et al (2008) Comparison of different treatment approaches for one to two brain metastases in elderly patients. Strahlenther Onkol 184:565–571
Maher E (1994) How long have I got doctor? Eur J Cancer 3:283–284
Hwang SS, Scott CB, Chang VT et al (2004) Prediction of survival for advanced cancer patients by recursive partitioning analysis: role of Karnofsky performance status, quality of life, and symptom distress. Cancer Invest 22:678–687
Vigano A, Dorgan M, Buckingham J et al (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363–374
Kaal EC, Taphoorn MJ, Vecht CJ (2005) Symptomatic management and imaging of brain metastases. J Neurooncol 75:15–20
Meyers C, Smith J, Bezjak A et al (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165
Broadbent A, Hruby G, Tin M et al (2004) Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. Radiother Oncol 71:259–265
Murray K, Scott C, Zachariah B et al (2000) Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. Int J Radiat Oncol Biol Phys 48:59–64
Brown P, Buckner J, O’Fallon J et al (2004) Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys 59:117–125
Pereira J, Hanson J, Bruera E (1997) The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79:835–842
Meyers C, Hess K, Yung A et al (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18: 646–650
Maione P, Perrone F, Gallo C et al (2005) Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol 23:6865–6872
Meyer HA, Sinnott C, Seed PT (2003) Depressive symptoms in advanced cancer. Part 2. Depression over time; the role of the palliative care professional. Palliat Med 17:604–607
Meyers C (2003) The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558
Patchell RA, Tibbs PA, Walsh JW et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500
Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sabater, S., Mur, E., Müller, K. et al. Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases. Clin Transl Oncol 14, 43–49 (2012). https://doi.org/10.1007/s12094-012-0760-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0760-z